Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Receivables - Net (2016 - 2025)

Fortress Biotech (FBIO) has 11 years of Receivables - Net data on record, last reported at $18.0 million in Q3 2025.

  • For Q3 2025, Receivables - Net rose 68.52% year-over-year to $18.0 million; the TTM value through Sep 2025 reached $18.0 million, up 68.52%, while the annual FY2024 figure was $10.2 million, 32.79% down from the prior year.
  • Receivables - Net reached $18.0 million in Q3 2025 per FBIO's latest filing, up from $15.6 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $31.7 million in Q3 2021 and bottomed at $8.0 million in Q3 2023.
  • Average Receivables - Net over 5 years is $20.0 million, with a median of $18.7 million recorded in 2021.
  • Peak YoY movement for Receivables - Net: surged 677.56% in 2021, then tumbled 72.0% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $23.1 million in 2021, then grew by 22.05% to $28.2 million in 2022, then crashed by 46.04% to $15.2 million in 2023, then crashed by 32.79% to $10.2 million in 2024, then surged by 75.77% to $18.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $18.0 million in Q3 2025, $15.6 million in Q2 2025, and $18.0 million in Q1 2025.